Trial Profile
Phase 1a initial single dose study of AV-101 in healthy volunters
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Apr 2023
Price :
$35
*
At a glance
- Drugs AV 101 (Primary) ; Imatinib
- Indications Neuropathic pain
- Focus Adverse reactions
- 29 Mar 2023 According to Aerovate media release, trial data published in ERJ Open Research and presented at the American Thoracic Society (ATS) International Conference in May.
- 22 Jun 2017 Results from this trial published in a VistaGen Therapeutics Media Release.
- 22 Jun 2017 According to a VistaGen Therapeutics media release, results from this study published in the Scandinavian Journal of Pain.